The Globe and Mail reports in its Friday, Nov. 7, edition that National Bank Financial analyst Zachary Evershed continues to rank Dexterra Group "outperform." The Globe's David Leeder writes in the Eye On Equities column that Mr. Evershed gave his share target a 50-cent boost to $15.50. Analysts on average target the shares at $12.51. Mr. Evershed says in a note: "The integration of the Right Choice acquisition and expansion efforts, particularly in the U.S. through the PVC partnership, remain key strategic priorities. Management expects Right Choice's integration to be fully completed by Q1/26, creating opportunities to reallocate equipment and maintain flexibility for potential nation building initiatives and other strategic programs while the ongoing optimization of assets in the Montney/Duverney area is underway, consolidating sites (notably those that share the same customers) to raise camp utilization in the area while freeing up spare assets for redeployment." The Globe reported on Aug. 1 and Oct. 7 that Mr. Evershed continued to rate Dexterra Group "outperform." The shares could then be had for $9.55 and $9.95.